Patrik Brundin
39 results.
When it comes to finding a cure for Parkinson’s disease, developing a way to shield vulnerable brain cells from damage is at the top of…
With the end of the year approaching, we asked the Institute’s leadership for a sneak peek into what they are most excited for in the…
Nov. 9, 2017 (GRAND RAPIDS, Mich.)—The Department of Defense has awarded a multi-institutional team of scientists a series of grants totaling $4.37 million to investigate…
For the seven to 10 million people worldwide with Parkinson’s disease, a medication that actually slows down their disease and staves off its debilitating symptoms…
For the first time, scientists can monitor the spread of a toxic protein linked to Parkinson’s in a model of the disease in real time.…
Evidence continues to mount that a newer class of anti-diabetic drugs called incretin mimetics, or glucagon-like peptide-1 receptor agonists, could slow…
New disease primer from Nature Journals offers updates on the cutting edge of Parkinson’s research and trends Discovery and innovation are moving quickly in the…
A major clue to understanding Parkinson’s and other neurodegenerative diseases may be right in front of our faces. Or rather, on our faces. At…